Coronis Partners

About

Coronis invested in a portfolio of ten highly selected Biotechnology and Biopharmaceutical companies, out of which five reached public trading in Israel and the US (BiondVax Ltd., Evogene Ltd., Rosetta Genomics Ltd., Prolor Biotech Ltd. and Glycominds Ltd.). Sinse 2012 Coronis operates as a specialty pharma company, focusing on the clinical development of in-licensed de-risked therapeutic molecules in multiple fields including neurobiology and ophthalmology.

Investment Focus

Location

Ness Ziona, Israel